Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Solventum Corporation SOLV

Healthcare  —  Medical Instruments & Supplies
89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
S&P 500 Member Revenue Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Solventum Corporation (SOLV) EV/EBITDA

As of 25 September 2026, Solventum Corporation (SOLV) trades at a EV/EBITDA of 7.9×. Over the past ten years it has ranged from 5.2× (March 2024) to 16.1× (July 2025); the current reading is higher than 43% of that period. That is below the Medical Instruments & Supplies industry median of 16.1× and below the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 6.8× (42.44%)
FY2024 11.7× 94.29%
FY2023 6.0× 0.00%
FY2022 6.0× —

Quarterly

Period EV/EBITDA Change
Jun 2026 7.1× 14.04%
Mar 2026 6.2× (8.55%)
Dec 2025 6.8× 12.45%
Sep 2025 6.0× (61.78%)
10 more quarters

Against its own ten years

Low 5.2× High 16.1×
Ten-year median 8.2×
Current reading's percentile 43

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation 7.9×
ATR AptarGroup, Inc. compare 11.5×
ALGN Align Technology, Inc. compare 11.7×
ALC Alcon compare 12.7×
BAX Baxter International Inc. compare 13.3×
COO The Cooper Companies, Inc. compare 14.1×
WST West Pharmaceutical Services, Inc. compare 30.2×
RGEN Repligen Corporation compare 65.3×
AVTR Avantor, Inc. compare 110×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SOLV